Zeria Pharmceutical Co., Ltd.TSE 4559

ゼリア新薬工業株式会社 · Pharmaceutical · FY ends Mar

Share price at FY-end
¥2,186
FY ending Mar 2026
Market cap at FY-end
¥110B
Dividend per share
¥49.0
Avg. director pay
¥73.8M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 Ibe Ltd.
Asset-management company of Koichi Ibe
5,330,000 12.09% ¥11.7B ¥261M
2 日本マスタートラスト信託銀行株式会社 3,233,000 7.34% ¥7.1B ¥158M
3 株式会社三菱UFJ銀行 2,107,000 4.78% ¥4.6B ¥103M
4 Koichi Ibe 1,592,000 3.61% ¥3.5B ¥78.0M
5 Morinaga Milk Industry Co., Ltd. 1,472,000 3.34% ¥3.2B ¥72.1M
6 株式会社三井住友銀行 1,406,000 3.19% ¥3.1B ¥68.9M
7 株式会社みずほ銀行 1,406,000 3.19% ¥3.1B ¥68.9M
8 Sumitomo Mitsui Card Co., Ltd. 900,000 2.04% ¥2.0B ¥44.1M
9 Kissei Pharmaceutical Co., Ltd. 867,000 1.97% ¥1.9B ¥42.5M
10 ゼリア新薬工業従業員持株会 766,000 1.74% ¥1.7B ¥37.5M

Officers' holdings and pay

NameTitleSharesValuePay
Koichi Ibe Chairman & CEO, Representative Director 1,592,000 ¥3.5B —
伊部 充弘 President & Representative Director, COO 93,000 ¥203M —
小森 哲夫 Director 8,000 ¥17.5M —
野本 亀久雄 Director — — —
森元 誠二 Director 1,000 ¥2.2M —
岡澤 有輝 Director 17,000 ¥37.2M —
遠藤 広和 Full-time Audit & Supervisory Board Member 83,000 ¥181M —
黒田 博之 Full-time Audit & Supervisory Board Member 2,000 ¥4.4M —
中 由規子 Audit & Supervisory Board Member 8,000 ¥17.5M —
紙透 大 Audit & Supervisory Board Member 1,000 ¥2.2M —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Mar 2026 ¥2,186 ¥191.80 11.4x ¥49.0 50,119,190
FY ending Mar 2025 ¥2,254 ¥225.42 10.0x ¥47.0 53,119,190
FY ending Mar 2024 ¥2,140 ¥175.39 12.2x ¥44.0 53,119,190
FY ending Mar 2023 ¥2,244 ¥140.26 16.0x ¥40.0 53,119,190
Source: annual securities reports on EDINET. Values are estimates. Methodology